These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17107277)

  • 1. A historical sketch of the discovery and development of HIV-1 integrase inhibitors.
    Savarino A
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1507-22. PubMed ID: 17107277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of integrase inhibitors as anti-HIV agents.
    Gupta SP; Nagappa AN
    Curr Med Chem; 2003 Sep; 10(18):1779-94. PubMed ID: 12871104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Raltegravir: the first HIV integrase inhibitor. Introduction].
    Gatell JM
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():1-2. PubMed ID: 19572418
    [No Abstract]   [Full Text] [Related]  

  • 5. New developments in diketo-containing inhibitors of HIV-1 integrase.
    Zhao G; Wang C; Liu C; Lou H
    Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of authentic inhibitors of HIV-1 integration.
    Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
    Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitors of HIV-1 integration.
    Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z
    Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV-1 integrase drugs: how far from the shelf?
    Pani A; Marongiu ME
    Curr Pharm Des; 2000 Mar; 6(5):569-84. PubMed ID: 10788597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV integrase as a target for antiretroviral therapy.
    Hazuda DJ
    Curr Opin HIV AIDS; 2012 Sep; 7(5):383-9. PubMed ID: 22871634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
    Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of HIV therapy: the new challenges.
    Perno CF
    Ann Ist Super Sanita; 2011; 47(1):41-3. PubMed ID: 21430337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral drugs.
    De Clercq E
    Curr Opin Pharmacol; 2010 Oct; 10(5):507-15. PubMed ID: 20471318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 integrase inhibitors: update and perspectives.
    Semenova EA; Marchand C; Pommier Y
    Adv Pharmacol; 2008; 56():199-228. PubMed ID: 18086413
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-1 integration as a target for antiretroviral therapy: a review.
    Pluymers W; De Clercq E; Debyser Z
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):133-49. PubMed ID: 12455410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to inhibitors of the human immunodeficiency virus type 1 integration.
    Hazuda DJ
    Braz J Infect Dis; 2010; 14(5):513-8. PubMed ID: 21221483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?
    Phillips EJ; Tseng A
    Can J Clin Pharmacol; 2002; 9(3):120-2. PubMed ID: 12422248
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrase inhibitors in the treatment of HIV-1 infection.
    Powderly WG
    J Antimicrob Chemother; 2010 Dec; 65(12):2485-8. PubMed ID: 20852268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.